Get four certifications in a row! Tianlong Science and Technology E. coli and other nucleic acid kits obtained CE certification and entered the EU market!

Industry news | 17 August, 2022 | CACLP

Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification. This is also another international authoritative registration certificates obtained by the company after a series of CE certification products such as monkeypox virus nucleic acid detection reagents.

So far, Tianlong products have obtained more than 120 EU CE, as well as the United States, the United Kingdom, Germany, the Netherlands, South Korea, Japan, Ukraine, Kazakhstan, Indonesia and other international registration certification, and have been widely used in more than 80 countries and regions around the world, This is the recognition of Tianlong's product quality by countries all over the world.

Catalogue of Tianlong testing reagents that have obtained EU CE certification

Life science system

Fever respiratory series	Fever with rash series	Diarrhea series	Fever with bleeding series	Encephalitis meningitis series
Flu virus	EU	Escherichia coli	Hantaan/Seoul virus	GBS
Bird flu virus	CA6/CA10	Vibrio cholerae	Yellow fever virus	Herpes virus
Middle East Respiratory Syndrome Coronavirus	EV71/CA16/EU	Norovirus	Ebola virus	Listeria monocytogenes
Respiratory syncytial virus	Dengue virus	Astrovirus		Other series
MP	Zika	Rotavirus		Monkeypox virus
TB	Chikungunya virus	Salmonella
Human adenovirus		Shigella
Human metapneumovirus		Staphylococcus aureus
COVID-19		Staphylococcus aureus

Clinical system

Prenatal and postnatal care	Genetic disease	Tumor detection	Drug Metabolism genetic testing	STD
HSv-II	Human leukocyte antigen B27	EB virus	Folic acid metabolic capacity MTHFR/MTRR	NG
HSv-II	SMN1	K-ras gene mutation	Allopurinol HLA-B*5801	UU
GBS	Respiratory tract	B-raf gene V600E mutation	Clopidogrel CYP2C19	HPV16+2
Hand, foot and mouth disease	COVID-19 2019-nCov		Gene testing for hypertension medication
Universal EU	MP		Carbamazepine HLA-B*1502
CA6/CA10	TB		Nitroglycerin Medication/Alcohol Metabolism ALDH2
EV71/CA16/EU	Influenza virus FluA/B
	Ebola virus
	Pertussis bacillus
	Legionella pneumophila

Comprehensive, efficient and accurate, Tianlong Intelligent Manufacturing is widely used in various fields

Tianlong reagent products are accurate and efficient, and cooperate with a series of automated nucleic acid extraction and amplification detection equipment to more fully realize the automated detection of pathogen nucleic acid. Tianlong Intelligent Manufacturing has been applied in many fields such as the prevention and control of the global COVID-19 epidemic, detection of various emergent infectious diseases, diagnosis of genetic diseases, personalized medicine, tumor diagnosis and treatment, food safety, animal disease quarantine, etc. And Tianlong has received high praise from internal and external customers.

In the future, Tianlong Science and Technology will continue to pay attention to global public health trends, and provide first-class molecular diagnostic products and overall solutions for the protection of life and health.

Filed under：

certificate EUA

Press contact

CACLP - The largest IVD Expo & Conference

Back to list

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

Name *
Email *
Company name *
Country *

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Get four certifications in a row! Tianlong Science and Technology E. coli and other nucleic acid kits obtained CE certification and entered the EU market!

Catalogue of Tianlong testing reagents that have obtained EU CE certification

Life science system

Clinical system

Comprehensive, efficient and accurate, Tianlong Intelligent Manufacturing is widely used in various fields

Most popular

In Vitro Diagnostic Industry in China - Molecular Diagnosis Analyzers and Reagents V

Diasorin Reports Another Quarter with Revenues And Profitability in Expansion, Raising the Full-Year 2024 Revenue Guidance

Siemens Healthineers Achieves Targets for 2024 Fiscal Year with Strong Fourth Quarter

Veracyte Announces Third Quarter 2024 Financial Results

Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification

Stay in touch with CACLP News

Subscribe to CACLP News

Thank you for subscribing to CACLP News!